Tornado aftermath: Pfizer plant damage in NC unlikely to disrupt drug supply

The U.S. FDA does not anticipate significant impacts on drug supply following the tornado damage to a Pfizer facility in North Carolina. The FDA is working with Pfizer to assess the impact and availability of affected products, considering stock in other warehouses and distribution systems. While fewer than 10 drugs may be affected, the FDA has initiated mitigation steps, such as seeking additional sources and asking other manufacturers to ramp up production if needed. Allocation measures may lead to localized supply disruptions, but a resilient drug supply chain is crucial for public health and national security. Pfizer is exploring alternative manufacturing locations to fill production gaps while the damaged site is repaired.